Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
03/1995
03/16/1995WO1995007099A1 Vaccine and process for producing the same
03/16/1995WO1995007073A1 Chemically-defined non-polymeric valency platform molecules and conjugates thereof
03/16/1995WO1995004151A3 Vaccine compositions containing recombinant tetc-fusion proteins
03/16/1995WO1995003415A3 Epstein-barr virus dna sequences encoding a diagnostically relevant virus capsid antigen, expression clones derived through polymerase chain reaction and the use of this recombinant antigen in diagnostic tests
03/16/1995WO1995003328A3 Melanoma-inhibiting protein
03/16/1995WO1995000643A3 Human cell adhesion protein aamp-1 and uses thereof
03/16/1995WO1994026886A3 Process for the preparation of immunogens or diagnostic reagents, and immunogens or diagnostic reagents thereby obtainable
03/16/1995CA2171211A1 Haplotype-matched cytokine-secreting cells and methods of using to stimulate an immune response
03/16/1995CA2171193A1 Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins
03/16/1995CA2170623A1 Diagnostic, prognostic, and therapeutic methods for solid non-lymphoid tumors and their metastases
03/15/1995EP0643077A1 Monoclonal antibody against B70 molecule
03/15/1995EP0642798A2 Chemically-defined non-polymeric valency platform molecules and conjugates thereof
03/15/1995EP0642796A1 Salmonella live vaccines
03/15/1995EP0642589A1 Method and reagent for inhibiting viral replication
03/15/1995EP0642584A1 Nucleic acid corresponding to a gene of chromosome 22 involved in recurrent chromosomal translocations associated with the development of cancerous tumors
03/15/1995EP0642582A1 Hybrid siv/hiv-1 viral vectors and monkey model for aids
03/15/1995EP0642581A1 Clostridium perfringens vaccines
03/15/1995EP0642577A1 Antibodies with specificity for multiple adhesion molecules
03/15/1995EP0642532A1 Proteinoid carriers and methods for preparation and use thereof
03/15/1995EP0642507A1 Catalytic antibodies against cocaine and methods of using and producing same
03/15/1995EP0642356A1 Antibodies to p-selectin and their uses
03/15/1995EP0642355A1 Combined vaccines comprising hepatitis b surface antigen and other antigens
03/15/1995EP0642354A1 METHODS FOR DETECTING AND ISOLATING uPA-R AND INHIBITING THE BINDING OF uPA TO uPA-R
03/15/1995EP0642348A1 Antibiotic cryptdin peptides and methods of their use
03/15/1995EP0414741B1 Further improvements relating to drug delivery systems
03/14/1995US5397703 Method for generation of antibodies to cell surface molecules
03/14/1995US5397702 Assay for and treatment of autoimmune diseases
03/14/1995US5397696 Papua New Guinea human T-lymphotropic virus
03/14/1995US5397569 Method of treating Infectious Bursal Disease Virus infections
03/14/1995US5397568 Method of treating infectious bursal disease virus infections
03/09/1995WO1995006748A1 Monoclonal antibody that induces apoptosis
03/09/1995WO1995006738A1 B70(b7-2):ctla-4 bonding protein
03/09/1995WO1995006734A1 Cloning of a member of the serine-threonine-kinase family
03/09/1995WO1995006732A2 Bacterial exported proteins and acellular vaccines based thereon
03/09/1995WO1995006729A1 Differentially expressed leishmania genes and proteins
03/09/1995WO1995006728A2 T cell epitopes of ryegrass pollen allergen
03/09/1995WO1995006727A2 Uses of myelin oligodendrocyte glycoprotein and peptide portions thereof in protocols related to autoimmune disease
03/09/1995WO1995006726A2 Dna molecule encoding for cellular uptake of mycobacterium tuberculosis
03/09/1995WO1995006725A1 Immunoreactive peptide sequence from a 43 kd human cancer antigen
03/09/1995WO1995006666A1 Anti-gp39 antibodies and uses therefor
03/09/1995WO1995006664A1 Dna encoding prostaglandin receptor ep2
03/09/1995WO1995006662A1 Neuron regulatory factor for promoting neuron survival
03/09/1995WO1995006657A1 Interleukin-10 and immunosuppression
03/09/1995WO1995006481A1 Methods for inducing antigen-specific t cell tolerance
03/09/1995WO1995006480A1 Methods of prolonged suppression of humoral immunity
03/09/1995WO1995006415A1 Senescent cell-derived inhibitors of dna synthesis
03/09/1995CA2170901A1 Uses of myelin oligodendrocyte glycoprotein and peptide portions thereof in protocols related to autoimmune disease
03/09/1995CA2170751A1 Neuron regulatory factor for promoting neuron survival
03/09/1995CA2170726A1 Bacterial exported proteins and acellular vaccines based thereon
03/09/1995CA2170393A1 Cloning of a member of the serine-threonine-kinase family
03/09/1995CA2170390A1 Immunoreactive peptide sequence from a 43 kd human cancer antigen
03/09/1995CA2170148A1 Dna molecule encoding for cellular uptake of mycobacterium tuberculosis
03/09/1995CA2169950A1 Monoclonal antibody that induces apoptosis
03/09/1995CA2168565A1 T cell epitopes of ryegrass pollen allergen
03/08/1995EP0641568A1 Chlamydia antigen, process for its manufacture and its use
03/08/1995EP0641385A1 Development of dna probes and immunological reagents of human tumor associated antigens
03/08/1995EP0641357A1 Hiv protein epitopes immunologically homologous to hla
03/08/1995EP0641220A1 Methods and agents for modulating immune response, and uses thereof
03/08/1995EP0641207A1 Enantiomeric cynemicin analogs, preparation and use thereof
03/08/1995EP0500641B1 Control of milk secretion
03/08/1995EP0484382B1 Feline calicivirus capsid protein and nucleotide sequence
03/08/1995CN1099798A Hepatitis a virus vaccine
03/07/1995US5395825 Medical diagnosis of infertility in females
03/07/1995US5395764 Promoter of the gene which codes for the pilinic subunit fim3 of Bordetella pertussis and its use for the expression in Bordetella of the genes which code for a protein of interest
03/07/1995US5395759 Vaccines, medical diagnosis
03/07/1995US5395614 Vaccines reducing severity of blood-stage malaria
03/02/1995WO1995006250A1 Molecular clones producing recombinant dna antigens of the hards virus
03/02/1995WO1995006247A1 Natural killer cell-specific antigen and antibodies that identify the same
03/02/1995WO1995006124A1 Dampening of an immunodominant epitope of an antigen for use in plant, animal and human vaccines and immunotherapies
03/02/1995WO1995006123A1 Detection and prevention of mycoplasma hominis infection
03/02/1995WO1995006122A2 Recombinant alternaria alternata allergenes
03/02/1995WO1995006121A2 Recombinant cladosporium herbarum allergens
03/02/1995WO1995006119A1 Recombinant humanized anti-human immunodeficiency virus antibody
03/02/1995WO1995006117A1 Human 5-ht2 receptor
03/02/1995WO1995006067A1 Monoclonal antibodies for use in diagnosis and treatment of colorectal cancer
03/02/1995WO1995006065A1 Cytokines that bind the cell surface receptor hek
03/02/1995WO1995006055A1 Hsv-2 ul26 gene, capsid proteins, immunoassays and protease inhibitors
03/02/1995WO1995005853A1 Method, compositions and devices for administration of naked polynucleotides which encode biologically active peptides
03/02/1995WO1995005850A1 Campylobacter jejuni antigens, and methods for their production and use
03/02/1995WO1995005849A1 Inducing antibody response against self-proteins with the aid of foreign t-cell epitopes
03/02/1995WO1995005847A1 Accessory factor function for interferon gamma and its receptor
03/02/1995WO1995005839A1 Nigella sativa as a medicinal treatment
03/02/1995WO1995005810A1 Compositions and methods for the detection and treatment of protein trafficking disorders and increasing secretory protein production
03/02/1995WO1995003418A3 Recombinant bcg vaccines
03/02/1995WO1995003414A3 Chicken anemia virus mutants and vaccines and uses based on the viral proteins vp1, vp2 and vp3 or sequences of that virus coding therefor
03/02/1995WO1994025601A3 New sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents
03/02/1995DE4425481A1 Melanoma-inhibiting protein
03/02/1995CA2623540A1 Dampening of an immunodominant epitope of an antigen for use in plant, animal and human vaccines and immunotherapies
03/02/1995CA2170356A1 Recombinant cladosporium herbarum allergens
03/02/1995CA2170355A1 Recombinant alternaria alternata allergenes
03/02/1995CA2170352A1 Natural killer cell-specific antigen and antibodies that identify the same
03/02/1995CA2169956A1 Nigella sativa as a medicinal treatment
03/02/1995CA2169851A1 Cytokines that bind the cell surface receptor hek
03/02/1995CA2169849A1 Accessory factor function for interferon gamma and its receptor
03/02/1995CA2169755A1 Detection and prevention of mycoplasma hominis infection
03/02/1995CA2169748A1 Hsv-2 ul26 gene, capsid proteins, immunoassays and protease inhibitors
03/02/1995CA2169210A1 Compositions and methods for the detection and treatment of protein trafficking disorders and increasing secretory protein production
03/02/1995CA2168030A1 Molecular clones producing recombinant dna antigens of the hards virus
03/02/1995CA2167691A1 Campylobacter jejuni antigens, and methods for their production and use
03/01/1995EP0640620A2 Methods and reagents for inhibiting cholesterol absorption in humans mediated by pancreatic esterase receptor protein
1 ... 1670 1671 1672 1673 1674 1675 1676 1677 1678 1679 1680 1681 1682 1683 1684 1685 1686 1687 1688 1689 1690 ... 1823